|
시장보고서
상품코드
2055127
진단 서비스 시장 : 서비스 유형별Diagnostic Services Market, By Service Type (Pathology/Laboratory, and Radiology/Diagnostic Imaging, By Test Type, By Application, By End User, By Payer, By Geography ) |
||||||
진단 서비스 시장은 2026년에 3,103억 달러로 추정되며, 2033년까지 6,163억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 10.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 3,103억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.30% | 2033년 시장 규모 예측 : | 6,163억 2,000만 달러 |
세계 진단 서비스 시장은 헬스케어 생태계의 핵심 구성 요소로, 정확한 질병 감지, 모니터링 및 치료 지침을 가능하게 하는 종합적인 의료 검사, 선별 검사 및 분석 서비스를 포함합니다. 이 시장에는 병원, 클리닉, 진단센터 및 재택치료 현장에 서비스를 제공하는 임상 검사, 의료 영상 진단 서비스, 병리 진단 서비스, 현장 진단(POCT) 솔루션 등 다양한 진단 기법이 포함됩니다.
진단 서비스 분야는 기술의 발전에 따라 급속히 진화하고 있으며, 인공지능, 분자진단, 디지털 병리학을 도입함으로써 의료 검사의 정확성, 속도 및 접근성을 향상시키고 있습니다. 시장의 성장세는 전 세계적인 고령화, 만성 질환 유병률 증가, 건강 관리에 대한 인식 제고, 그리고 혁신적인 진단 기술의 지속적인 개발에 힘입어 견인되고 있습니다. 의료 서비스 제공업체들은 맞춤형 의료 제공, 환자 예후 개선, 치료 프로토콜 최적화를 위해 첨단 진단 서비스에 대한 의존도를 높이고 있습니다. 원격 의료 및 원격 모니터링 기능의 통합으로 진단 서비스의 범위가 더욱 확대되었습니다. 특히, 공중보건상의 과제에 대응하고 다양한 지리적 지역에서 의료 서비스의 지속성을 확보하는 데 있어 신속하고 정확하며 이용하기 쉬운 진단 솔루션의 중요성이 부각된 코로나19 팬데믹이 이러한 확대를 가속화했습니다.
시장 역학
세계 진단 서비스 시장은 전 세계 의료 시스템 전반의 꾸준한 성장을 전반적으로 뒷받침하는 몇 가지 주요 촉진요인에 의해 주도되고 있습니다. 주요 성장 요인은 전 세계 인구의 급속한 고령화와 이에 따른 당뇨병, 심혈관 질환, 암, 신경계 질환 등 만성 질환의 급증에 있으며, 이러한 질환들은 지속적인 모니터링과 정교한 진단 및 치료가 필요합니다. 인공지능(AI) 통합, 분자진단, 액체 생검, 차세대 염기서열 분석(NGS) 등의 기술적 진보는 진단의 정확성과 효율성에 혁명을 일으켰으며, 의료 서비스 제공업체가 맞춤형 치료 접근법을 제공할 수 있게 했습니다. 예방 의료의 실천과 정기적인 검진 프로그램 도입이 확대됨에 따라 진단 서비스에 대한 수요가 크게 증가하고 있으며, 한편으로는 질병의 조기 발견과 의료 인프라 구축을 촉진하는 정부의 이니셔티브이 시장 성장을 더욱 가속화하고 있습니다.
그러나 시장에는 첨단 진단 장비나 절차에 따른 높은 비용 등 상당한 제약이 존재합니다. 이는 특히 의료 예산이 제한적인 개발도상국에서 접근의 장벽이 되고 있습니다. 신규 진단 기술에 대한 엄격한 규제 요건과 장기화되는 승인 절차는 시장 진입 및 혁신 도입에 걸림돌이 되고 있습니다. 게다가, 첨단 진단 장비를 다룰 수 있는 숙련된 의료진이나 기술자의 부족은 서비스 제공업체에게 운영상의 과제가 되고 있습니다.
이러한 제약이 있음에도 불구하고, 신흥국에서의 의료 인프라 확충, 재택 및 현장 진단(POC) 솔루션에 대한 수요 증가, 그리고 정밀 의학 및 동반 진단에 대한 투자 확대로 인해 큰 기회가 창출되고 있습니다. 디지털 헬스 기술, 원격 의료 플랫폼, 원격 모니터링 기능의 통합은 시장 확대를 위한 유망한 기회를 제공합니다. 특히, 의료 시스템이 다양한 의료 환경에서 진단의 품질과 신뢰성을 유지하면서도 환자의 접근성을 개선할 수 있는 비용 대비 효과가 높은 솔루션을 필요로 하고 있기 때문에 그 가능성은 더욱 높아지고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 진단 서비스 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 진단 서비스 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 진단 서비스 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 진단 서비스 시장 : 서비스 유형별, 2021년-2033년
제5장 세계의 진단 서비스 시장 : 테스트 유형별, 2021년-2033년
제6장 세계의 진단 서비스 시장 : 용도별, 2021년-2033년
제7장 세계의 진단 서비스 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 진단 서비스 시장 : 지불 주체별, 2021년-2033년
제9장 세계의 진단 서비스 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.22Diagnostic Services Market is estimated to be valued at USD 310.30 Bn in 2026 and is expected to reach USD 616.32 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 310.30 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.30% | 2033 Value Projection: | USD 616.32 Bn |
The global diagnostic services market represents a critical component of the healthcare ecosystem, encompassing a comprehensive range of medical testing, screening, and analytical services that enable accurate disease detection, monitoring, and treatment guidance. This market includes various diagnostic modalities such as clinical laboratory testing, medical imaging services, pathology services, and point-of-care testing solutions that serve hospitals, clinics, diagnostic centers, and home healthcare settings.
The diagnostic services sector has evolved significantly with technological advancements, incorporating artificial intelligence, molecular diagnostics, and digital pathology to enhance accuracy, speed, and accessibility of medical testing. The market's growth trajectory is driven by an aging global population, increasing prevalence of chronic diseases, rising healthcare awareness, and the continuous development of innovative diagnostic technologies. Healthcare providers increasingly rely on sophisticated diagnostic services to deliver personalized medicine, improve patient outcomes, and optimize treatment protocols. The integration of telemedicine and remote monitoring capabilities has further expanded the scope of diagnostic services, particularly accelerated by the COVID-19 pandemic which highlighted the critical importance of rapid, accurate, and accessible diagnostic solutions in managing public health challenges and ensuring continuity of healthcare delivery across diverse geographical regions.
Market Dynamics
The global diagnostic services market is propelled by several key drivers that collectively fuel its robust expansion across healthcare systems worldwide. The primary growth driver stems from the rapidly aging global population and the corresponding surge in chronic diseases such as diabetes, cardiovascular disorders, cancer, and neurological conditions, which require continuous monitoring and sophisticated diagnostic interventions. Technological advancements including artificial intelligence integration, molecular diagnostics, liquid biopsies, and next-generation sequencing have revolutionized diagnostic accuracy and efficiency, enabling healthcare providers to deliver personalized treatment approaches. The increasing adoption of preventive healthcare practices and routine screening programs has significantly expanded the demand for diagnostic services, while government initiatives promoting early disease detection and healthcare infrastructure development further accelerate market growth.
However, the market faces considerable restraints including high costs associated with advanced diagnostic equipment and procedures, which limit accessibility particularly in developing regions with constrained healthcare budgets. Stringent regulatory requirements and lengthy approval processes for new diagnostic technologies create barriers to market entry and innovation adoption. Additionally, shortage of skilled healthcare professionals and technicians capable of operating sophisticated diagnostic equipment poses operational challenges for service providers.
Despite these constraints, substantial opportunities emerge from expanding healthcare infrastructure in emerging economies, growing demand for home-based and point-of-care diagnostic solutions, and increasing investments in precision medicine and companion diagnostics. The integration of digital health technologies, telemedicine platforms, and remote monitoring capabilities presents lucrative opportunities for market expansion, particularly as healthcare systems seek cost-effective solutions that improve patient accessibility while maintaining diagnostic quality and reliability across diverse healthcare settings.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global diagnostic services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings (LabCorp), Bio-Rad Laboratories Inc, Danaher Corporation (Beckman Coulter & Cepheid), Hologic Inc, GE HealthCare Technologies Inc, Philips Healthcare, Agilent Technologies Inc, QIAGEN N.V., PerkinElmer Inc (now Revvity), and Illumina Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global diagnostic services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic services market
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2021 - 2033)
- Pathology/Laboratory
- Clinical Chemistry
- Hematology
- Microbiology and Cytology
- Molecular Diagnostics
- Immunodiagnostics/Immunoassay
- Others (Histopathology)
- Radiology/Diagnostic Imaging
- X-ray
- Magnetic Resonance Imaging (MRI)
- Ultrasound
- Computed Tomography (CT) Scan
- Nuclear Imaging (PET, SPECT)
- Others (Mammography)
- Test Type Insights (Revenue, USD Bn, 2021 - 2033)
- Routine/Preventive Test
- Molecular and Genetic Test
- Point-of-Care Tests (POCT)
- Other Specialty Test
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Gastroenterology
- Orthopedics
- Gynecology and Obstetrics
- Other Applications (e.g., Infectious Diseases, Endocrinology)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Laboratories and Pathology Labs
- Research and Academic Institutes
- Home Healthcare/At-Home Testing
- Specialized Diagnostic Centers
- Payer Insights (Revenue, USD Bn, 2021 - 2033)
- Public
- Private
- Self-Pay (Out-of-Pocket Patients)
- Corporate/Employer-Sponsored Health Plans
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Siemens Healthineers AG
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings (LabCorp)
- Bio-Rad Laboratories Inc
- Danaher Corporation (Beckman Coulter & Cepheid)
- Hologic Inc
- GE HealthCare Technologies Inc
- Philips Healthcare
- Agilent Technologies Inc
- QIAGEN N.V.
- PerkinElmer Inc (now Revvity)
- Illumina Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Diagnostic Services Market, By Service Type
- Global Diagnostic Services Market, By Test Type
- Global Diagnostic Services Market, By Application
- Global Diagnostic Services Market, By End User
- Global Diagnostic Services Market, By Payer
- Global Diagnostic Services Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Diagnostic Services Market, By Service Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pathology/Laboratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical Chemistry
- Hematology
- Microbiology and Cytology
- Molecular Diagnostics
- Immunodiagnostics/Immunoassay
- Others (Histopathology)
- Radiology/Diagnostic Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- X-ray
- Magnetic Resonance Imaging (MRI)
- Ultrasound
- Computed Tomography (CT) Scan
- Nuclear Imaging (PET, SPECT)
- Others (Mammography)
5. Global Diagnostic Services Market, By Test Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Routine/Preventive Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Molecular and Genetic Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Point-of-Care Tests (POCT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Specialty Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Diagnostic Services Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Orthopedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gynecology and Obstetrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Applications (e.g., Infectious Diseases, Endocrinology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Diagnostic Services Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories and Pathology Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Healthcare/At-Home Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialized Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Diagnostic Services Market, By Payer, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Self-Pay (Out-of-Pocket Patients)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Corporate/Employer-Sponsored Health Plans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Diagnostic Services Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings (LabCorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation (Beckman Coulter & Cepheid)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer Inc (now Revvity)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
